Submitted by Anonymous (not verified) on 17 September 2025 - 10:24
Human medicines European public assessment report (EPAR): Zirabev, bevacizumab, Date of authorisation: 14/02/2019, Revision: 17, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Zirabev, bevacizumab, Date of authorisation: 14/02/2019, Revision: 17, Status: Authorised